132 related articles for article (PubMed ID: 18781329)
1. LRRK2 R1628P increases risk of Parkinson's disease: replication evidence.
Tan EK; Tan LC; Lim HQ; Li R; Tang M; Yih Y; Pavanni R; Prakash KM; Fook-Chong S; Zhao Y
Hum Genet; 2008 Oct; 124(3):287-8. PubMed ID: 18781329
[TBL] [Abstract][Full Text] [Related]
2. Confirmation of the association between LRRK2 R1628P variant and susceptibility to Parkinson's disease in the Thai population.
Pulkes T; Papsing C; Thakkinstian A; Pongpakdee S; Kulkantrakorn K; Hanchaiphiboolkul S; Tiamkao S; Boonkongchuen P
Parkinsonism Relat Disord; 2014 Sep; 20(9):1018-21. PubMed ID: 24997548
[TBL] [Abstract][Full Text] [Related]
3. LRRK2 R1628P contributes to Parkinson's disease susceptibility in Chinese Han populations from mainland China.
Yu L; Hu F; Zou X; Jiang Y; Liu Y; He X; Xi J; Liu L; Liu Z; He L; Xu Y
Brain Res; 2009 Nov; 1296():113-6. PubMed ID: 19699188
[TBL] [Abstract][Full Text] [Related]
4. Lrrk2 R1628P variant is a risk factor for essential tremor.
Chao YX; Ng EY; Tan L; Prakash KM; Au WL; Zhao Y; Tan EK
Sci Rep; 2015 Mar; 5():9029. PubMed ID: 25761573
[TBL] [Abstract][Full Text] [Related]
5. The association between the LRRK2 R1628P variant and the risk of Parkinson's disease in Asian: a meta-analysis.
Wang X; Zhang X; Xue L; Xie A
Neurosci Lett; 2016 Jun; 623():22-7. PubMed ID: 27133195
[TBL] [Abstract][Full Text] [Related]
6. LRRK2 R1628P variant is a risk factor of Parkinson's disease among Han-Chinese from mainland China.
Zhang Z; Burgunder JM; An X; Wu Y; Chen W; Zhang J; Wang Y; Xu Y; Gou Y; Yuan G; Mao X; Peng R
Mov Disord; 2009 Oct; 24(13):1902-5. PubMed ID: 19672984
[TBL] [Abstract][Full Text] [Related]
7. Analysis of Lrrk2 R1628P as a risk factor for Parkinson's disease.
Ross OA; Wu YR; Lee MC; Funayama M; Chen ML; Soto AI; Mata IF; Lee-Chen GJ; Chen CM; Tang M; Zhao Y; Hattori N; Farrer MJ; Tan EK; Wu RM
Ann Neurol; 2008 Jul; 64(1):88-92. PubMed ID: 18412265
[TBL] [Abstract][Full Text] [Related]
8. LRRK2 variant associated with Alzheimer's disease.
Zhao Y; Ho P; Yih Y; Chen C; Lee WL; Tan EK
Neurobiol Aging; 2011 Nov; 32(11):1990-3. PubMed ID: 20018409
[TBL] [Abstract][Full Text] [Related]
9. Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study.
Ross OA; Soto-Ortolaza AI; Heckman MG; Aasly JO; Abahuni N; Annesi G; Bacon JA; Bardien S; Bozi M; Brice A; Brighina L; Van Broeckhoven C; Carr J; Chartier-Harlin MC; Dardiotis E; Dickson DW; Diehl NN; Elbaz A; Ferrarese C; Ferraris A; Fiske B; Gibson JM; Gibson R; Hadjigeorgiou GM; Hattori N; Ioannidis JP; Jasinska-Myga B; Jeon BS; Kim YJ; Klein C; Kruger R; Kyratzi E; Lesage S; Lin CH; Lynch T; Maraganore DM; Mellick GD; Mutez E; Nilsson C; Opala G; Park SS; Puschmann A; Quattrone A; Sharma M; Silburn PA; Sohn YH; Stefanis L; Tadic V; Theuns J; Tomiyama H; Uitti RJ; Valente EM; van de Loo S; Vassilatis DK; Vilariño-Güell C; White LR; Wirdefeldt K; Wszolek ZK; Wu RM; Farrer MJ;
Lancet Neurol; 2011 Oct; 10(10):898-908. PubMed ID: 21885347
[TBL] [Abstract][Full Text] [Related]
10. The LRRK2 G2385R variant is a risk factor for sporadic Parkinson's disease in the Korean population.
Kim JM; Lee JY; Kim HJ; Kim JS; Shin ES; Cho JH; Park SS; Jeon BS
Parkinsonism Relat Disord; 2010 Feb; 16(2):85-8. PubMed ID: 19854095
[TBL] [Abstract][Full Text] [Related]
11. Lack of association between the LRRK2 A419V variant and Asian Parkinson's disease.
Gopalai AA; Lim SY; Aziz ZA; Lim SK; Tan LP; Chong YB; Tan CT; Puvanarajah S; Viswanathan S; Kuppusamy R; Tan AH; Lim TT; Eow GB; Norlinah MI; Li HH; Zhao Y; Ahmad-Annuar A
Ann Acad Med Singap; 2013 May; 42(5):237-40. PubMed ID: 23771111
[TBL] [Abstract][Full Text] [Related]
12. The LRRK2 Gly2385Arg variant is associated with Parkinson's disease: genetic and functional evidence.
Tan EK; Zhao Y; Skipper L; Tan MG; Di Fonzo A; Sun L; Fook-Chong S; Tang S; Chua E; Yuen Y; Tan L; Pavanni R; Wong MC; Kolatkar P; Lu CS; Bonifati V; Liu JJ
Hum Genet; 2007 Feb; 120(6):857-63. PubMed ID: 17019612
[TBL] [Abstract][Full Text] [Related]
13. Parkinson-Related LRRK2 Mutation R1628P Enables Cdk5 Phosphorylation of LRRK2 and Upregulates Its Kinase Activity.
Shu Y; Ming J; Zhang P; Wang Q; Jiao F; Tian B
PLoS One; 2016; 11(3):e0149739. PubMed ID: 26930193
[TBL] [Abstract][Full Text] [Related]
14. Confirmation of LRRK2 S1647T variant as a risk factor for Parkinson's disease in southern China.
Zheng Y; Liu Y; Wu Q; Hong H; Zhou H; Chen J; Wang H; Xian W; Li J; Liu Z; Pei Z; Chen L
Eur J Neurol; 2011 Mar; 18(3):538-40. PubMed ID: 20629711
[TBL] [Abstract][Full Text] [Related]
15. Association of LRRK2 R1628P variant with Parkinson's disease in Ethnic Han-Chinese and subgroup population.
Zhang P; Wang Q; Jiao F; Yan J; Chen L; He F; Zhang Q; Tian B
Sci Rep; 2016 Nov; 6():35171. PubMed ID: 27812003
[TBL] [Abstract][Full Text] [Related]
16. Relationship between LRRK2 R1628P polymorphism and Parkinson's disease in Asian populations.
Zhao H; Kong Z
Oncotarget; 2016 Jul; 7(30):46890-46898. PubMed ID: 27384489
[TBL] [Abstract][Full Text] [Related]
17. Brain-derived neurotrophic factor (BDNF) genetic polymorphism greatly increases risk of leucine-rich repeat kinase 2 (LRRK2) for Parkinson's disease.
Liu J; Zhou Y; Wang C; Wang T; Zheng Z; Chan P
Parkinsonism Relat Disord; 2012 Feb; 18(2):140-3. PubMed ID: 21924942
[TBL] [Abstract][Full Text] [Related]
18. Association between G2385R and R1628P polymorphism of LRRK2 gene and sporadic Parkinson's disease in a Han-Chinese population in south-eastern China.
Cai J; Lin Y; Chen W; Lin Q; Cai B; Wang N; Zheng W
Neurol Sci; 2013 Nov; 34(11):2001-6. PubMed ID: 23624603
[TBL] [Abstract][Full Text] [Related]
19. LRRK2 G2385R and R1628P mutations are associated with an increased risk of Parkinson's disease in the Malaysian population.
Gopalai AA; Lim SY; Chua JY; Tey S; Lim TT; Mohamed Ibrahim N; Tan AH; Eow GB; Abdul Aziz Z; Puvanarajah SD; Viswanathan S; Looi I; Lim SK; Tan LP; Chong YB; Tan CT; Zhao Y; Tan EK; Ahmad-Annuar A
Biomed Res Int; 2014; 2014():867321. PubMed ID: 25243190
[TBL] [Abstract][Full Text] [Related]
20. SNCA but not DNM3 and GAK modifies age at onset of LRRK2-related Parkinson's disease in Chinese population.
Yang ZH; Li YS; Shi MM; Yang J; Liu YT; Mao CY; Fan Y; Hu XC; Shi CH; Xu YM
J Neurol; 2019 Jul; 266(7):1796-1800. PubMed ID: 31041581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
